Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cymabay Therapeutics, Inc. (CBAY)  
$32.48 0.00 (0.00%) as of 4:30 Thu 3/21


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 114,780,000
Market Cap: 3.73(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.47 - $32.48
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other chronic diseases. Co.'s pipeline includes the following clinical stage product candidates: seladelpar, a selective agonist for the peroxisome proliferator-activated receptor delta, which is a nuclear receptor that regulates genes involved in bile acid/sterol, lipid, and glucose metabolism, and regulation of certain inflammatory cells; and MBX-2982, which targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 51,301
Total Buy Value $0 $0 $0 $100,037
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 6,000 235,302 552,511 672,611
Total Sell Value $191,849 $4,692,766 $8,944,114 $10,085,429
Total People Sold 1 5 6 7
Total Sell Transactions 1 14 33 36
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 156
  Page 5 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Menold Daniel Vice President, Finance   •       –      –    2018-08-29 4 OE $5.00 $25,000 D/D 5,000 5,000     -
   Shah Sujal Chief Executive Officer   •       •      –    2018-07-27 4 B $10.90 $54,500 D/D 5,000 95,000 2.81     -
   Emster Kurt Von Director   –       •      –    2018-06-05 4 S $12.51 $11,509 I/I (920) 18,316     -
   Emster Kurt Von Director   –       •      –    2018-06-05 4 OE $5.75 $11,500 I/I 2,000 19,236     -
   Shah Sujal Chief Executive Officer   •       •      –    2018-05-11 4 B $10.65 $53,250 D/D 5,000 90,000 2.81     -
   Goldfischer Carl Director   –       •      –    2018-03-22 4 S $13.03 $195,375 D/D (15,000) 0     -
   Goldfischer Carl Director   –       •      –    2018-03-22 4 OE $5.00 $77,830 D/D 15,000 15,000     -
   Emster Kurt Von Director   –       •      –    2018-03-05 4 AS $15.51 $207,105 I/I (13,353) 273,417     -
   Emster Kurt Von Director   –       •      –    2018-02-15 4 AS $14.49 $995,637 I/I (68,712) 286,770     -
   Emster Kurt Von Director   –       •      –    2018-02-14 4 AS $16.69 $2,720,120 I/I (162,979) 355,482     -
   Emster Kurt Von Director   –       •      –    2018-02-13 4 AS $13.51 $744,104 I/I (55,078) 518,461     -
   Emster Kurt Von Director   –       •      –    2018-02-07 4 AS $12.35 $503,423 I/I (40,763) 419,693     -
   Emster Kurt Von Director   –       •      –    2018-02-05 4 AS $12.14 $228,608 I/I (18,831) 460,456     -
   Emster Kurt Von Director   –       •      –    2018-02-02 4 AS $12.11 $24,220 I/I (2,000) 479,287     -
   Emster Kurt Von Director   –       •      –    2018-02-01 4 AS $12.15 $1,070,391 I/I (88,098) 481,287     -
   Emster Kurt Von Director   –       •      –    2018-01-31 4 AS $12.23 $150,429 I/I (12,300) 569,385     -
   Emster Kurt Von Director   –       •      –    2018-01-30 4 AS $12.22 $1,042,843 I/I (85,339) 581,685     -
   Emster Kurt Von Director   –       •      –    2018-01-25 4 AS $12.18 $480,355 I/I (39,438) 667,024     -
   Emster Kurt Von Director   –       •      –    2018-01-22 4 AS $10.40 $1,437,831 I/I (138,253) 706,462     -
   Emster Kurt Von Director   –       •      –    2018-01-19 4 AS $10.25 $1,338,486 I/I (130,584) 844,715     -
   Emster Kurt Von Director   –       •      –    2018-01-18 4 AS $10.21 $139,183 I/I (13,632) 975,299     -
   Emster Kurt Von Director   –       •      –    2018-01-05 4 AS $10.21 $43,903 I/I (4,300) 988,931     -
   Emster Kurt Von Director   –       •      –    2017-12-22 4 AS $9.41 $1,629,304 I/I (173,192) 993,231     -
   Emster Kurt Von Director   –       •      –    2017-11-10 4 AS $9.26 $463,379 I/I (50,048) 1,166,423     -
   Mcwherter Charles SVP & Chief Scientific Officer   •       –      –    2017-11-02 4 B $8.67 $43,341 D/D 5,000 15,000 2.74     -

  156 Records found
  1  2  3  4  5  6  7   
  Page 5 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed